Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, even within Tregs the intensity of FOXP3 expression can change, with naive or resting populations of Tregs expressing lower levels of FOXP3 than activated Tregs [379, 380].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
The cited source says what the claim attributes to it.
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 2×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression ( 26 , 27), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression (26, 27 ), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Cited by
Items 401–500 of 875
Hartling, H. J., Gaardbo, J. C., Ronit, A., Knudsen, L. S., Ullum, H., Vainer, B., Clausen, M. R., Skogstrand, K., Gerstoft, J., & Nielsen, S. D. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02725.x · Cited by 38
Sun, W., LI, W.-J., Fu, Q., Wu, C. Y., Lin, J.-Z., Zhu, X., HOU, W.-J., Wei, Y. Z., Wen, Y.-H., WANG, Y.-J., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3553 · Cited by 34
Lu, P., Struijs, M.-C., Mei, J., Witte‐Bouma, J., Male, A. M. K.-V., de Bruijn, A. C. J. M., van Goudoever, J. B., & Renes, I. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078491 · Cited by 35
“However, detailed functional studies are needed to further confirm the important role of Treg in NEC recovery since FOXP3 can also be induced in activated T effector cells [42].”
BackgroundSpectrum of T‐lymphocyte activities regulating allergic lung inflammation
Gelfand, E. W., Joetham, A., Wang, M., Takeda, K., & Schedel, M. (2017) · Immunological Reviews · doi:10.1111/imr.12561 · Cited by 33
Janssens, I., & Cools, N. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104236 · Cited by 37
Positive and negative selection shape the human naive B cell repertoire
Chen, J. W., Schickel, J., Tsakiris, N., Sng, J., Arbogast, F., Bouis, D., Parisi, D., Gera, R., Boeckers, J. M., Delmotte, F. R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150985 · Cited by 32
Petrausch, U., Poehlein, C. H., Jensen, S. M., Twitty, C., Thompson, J., Assmann, I., Puri, S., LaCelle, M. G., Moudgil, T. L., Maston, L. D., et al. (2009) · Current Molecular Medicine · doi:10.2174/156652409788970670 · Cited by 31
CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer
Lam, J. H., Hong, M., Koo, S.-L., Chua, C. W. L., Lim, K. L., Wee, F., Wan, W. K., Leow, W. Q., Yeo, J. G., Tan, I. B. H., et al. (2021) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-021-02859-x · Cited by 31
Treg in inborn errors of immunity: gaps, knowns and future perspectives
Kennedy-Batalla, R., Acevedo, D., Luo, Y., Esteve‐Solé, A., Vlagea, A. D., Correa‐Rocha, R., Seoane-Reula, E., & Alsina, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1278759 · Cited by 39
“Using each marker separately is not a valid option, as Tconv cells may overexpress CD25, FoxP3, and Helios, and reduce CD127 expression under stimulation conditions (154, 161, 162).”
BackgroundLandskron, J., & Taskén, K. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.04.008 · Cited by 31
Brezar, V., Ruffin, N., Richert, L. E., Surénaud, M., Lacabaratz, C., Palucka, K., Thiébaut, R., Banchereau, J., Lévy, Y., & Seddiki, N. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004752 · Cited by 33
Lü, C.-X., Xu, R., Cao, M., Wang, G., Yan, F., Shang, S.-S., Wu, X.-F., Ruan, L., Quan, X., & Zhang, C. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.007 · Cited by 32
Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells
Zwang, N. A., & Leventhal, J. R. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111206 · Cited by 37
Slepicka, P. F., Yazdanifar, M., & Bertaina, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688460 · Cited by 34
“However, transient expression of FOXP3 in Teff cells did not correlate with regulatory functions previously reported in Tregs, indicating that FOXP3may not be used as a marker solely for Tregs (82).”
BackgroundLu, X., Liu, J., Li, H., Li, W., Wang, X., Ma, J., Tong, Q., Wu, K., & Wang, G. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.22005 · Cited by 35
“However, it has been suggested that ex vivo activated human T cells may also express Foxp3 [4].”
Backgroundde Sio, F. R. S., Passerini, L., Valente, M., Russo, F., Naldini, L., Roncarolo, M., & Bacchetta, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-15689-8 · Cited by 32
Self-citationFlow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells
Crellin, N. K., García, R., & Levings, M. K. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.05.008 · Cited by 31
Self-citationMacDonald, K. N., Ivison, S., Hippen, K. L., Hoeppli, R. E., Hall, M., Zheng, G., Dijke, I. E., Aklabi, M. A., Freed, D. H., Rebeyka, I., et al. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.10.011 · Cited by 30
Self-citationPerez-Novo, C. A., Jędrzejczak-Czechowicz, M., Lewandowska‐Polak, A., Claeys, C., Holtappels, G., Cauwenberge, P. V., Kowalski, M. L., & Bachert, C. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03577.x · Cited by 30
Schnell, A., Schmidl, C., Herr, W., & Siska, P. J. (2018) · Biomedicines · doi:10.3390/biomedicines6010025 · Cited by 36
“However, as opposed to murine T cells, FOXP3 is expressed in human T cells that are both immunosuppressive and inflammatory [97,98].”
BackgroundOne, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity
Sambucci, M., Gargano, F., Guerrera, G., Battistini, L., & Borsellino, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02947 · Cited by 32
Li, Y., Frei, A. W., Labrada, I. M., Rong, Y., Liang, J., Samojlik, M. M., Sun, C., BARASH, S. D., Keselowsky, B. G., Bayer, A. L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653088 · Cited by 34
“iTregs Induced by TGF-b1 PLGA Microparticles Are Functionally Suppressive Transient Foxp3 expression and non-function for in vitro induced human Tregs has been previously reported (56).”
BackgroundRole of CD4+CD25+FOXP3+TRegcells on tumor immunity
Hariyanto, A. D., Permata, T. B. M., & Gondhowiardjo, S. A. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1975228 · Cited by 36
Michelozzi, I. M., Gómez‐Castañeda, E., Pohle, R. V. C., Rodriguez, F. C., Sufi, J., Puigdevall, P., Subramaniyam, M., Kirtsios, E., Eddaoudi, A., Wu, S. W., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008490 · Cited by 31
Donor reactive regulatory T cells
Feng, G., Chan, T., Wood, K. J., & Bushell, A. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32832c58f1 · Cited by 30
Blood and Gastric FOXP3+ T Cells Are Not Decreased in Human Gastric Graft-versus-Host Disease
Lord, J. D., Hackman, R. C., Gooley, T. A., Wood, B. L., Moklebust, A., Hockenbery, D. M., Steinbach, G., Ziegler, S. F., & McDonald, G. B. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.09.015 · Cited by 30
Association of two clones allows for optimal detection of human FOXP3
Presicce, P., Moreno‐Fernandez, M. E., Lages, C. S., Orsborn, K. I., & Chougnet, C. A. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20875 · Cited by 29
The FOXP3+ subset of human CD4+CD8+ thymocytes is immature and subject to intrathymic selection
Tuovinen, H., Pekkarinen, P. T., Rossi, L. H., Mattila, I. P., & Arstila, T. P. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.36 · Cited by 30
Cutting Edge: Human CD4−CD8− Thymocytes Express FOXP3 in the Absence of a TCR
Tuovinen, H., Kekäläinen, E., Rossi, L. H., Puntila, J., & Arstila, T. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3651 · Cited by 30
Regulation of Regulatory T Cells
Okada, M., Hibino, S., Someya, K., & Yoshmura, A. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00008-x · Cited by 31
Tatura, R., Zeschnigk, M., Adamzik, M., Probst‐Kepper, M., Buer, J., & Kehrmann, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049962 · Cited by 35
Chinn, I. K., Milner, J. D., Scheinberg, P., Douek, D. C., & Markert, M. L. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12088 · Cited by 29
Sageshima, J., Ciancio, G., Guerra, G., Gaynor, J. J., Cova, D., Zarak, A., Chen, L., Mattiazzi, A. D., Kupin, W. L., Roth, D., et al. (2011) · Transplant Immunology · doi:10.1016/j.trim.2011.07.002 · Cited by 29
Allogeneic induced human FOXP3+IFN‐γ+ T cells exhibit selective suppressive capacity
Stroopinsky, D., Avivi, I. M., Rowe, J. M., Avigan, D., & Katz, T. (2009) · European Journal of Immunology · doi:10.1002/eji.200839097 · Cited by 30
Chera, M., Hamel, Y., Baillou, C., Touil, S., Guillot‐Delost, M., Charlotte, F., Kossir, L., Simonin, G., Maury, S., Cohen, J. L., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x683566 · Cited by 28
“As others (1,2), we observed that CD25 and CD127 could not anymore be discriminative markers between Tregs and Teffs after ex vivo expansion.”
BackgroundLord, J. D., Chen, J., Thirlby, R. C., Sherwood, A., & Carlson, C. S. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000242 · Cited by 30
“latter having been reported in humans to make cytokines and lack suppressive function.(11) Intestinal FOXP3+ Tregs from patients with IBD have been shown to have suppressive function when placed in artificial in vitro suppression assays but whether they do suppress”
BackgroundEras of designer Tregs: Harnessing synthetic biology for immune suppression
Tuomela, K., Salim, K., & Levings, M. K. (2023) · Immunological Reviews · doi:10.1111/imr.13254 · Cited by 32
“36 Specifically, in this pre-CRISPR era, we used single Tconv clones from a female carrier of a null IPEX mutation to demonstrate heightened T-cell proliferation and cytokine production in the absence of FOXP3.”
BackgroundMethodSelf-citationT regulatory cells in B‐cell malignancy – tumour support or kiss of death?
Lindqvist, C. A., & Loskog, A. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03539.x · Cited by 35
Åkesson, K., Tompa, A., Rydén, A., & Faresjö, M. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12559 · Cited by 31
Yapici, Ü., Bemelman, F. J., Scheepstra, C. G., Roelofs, J. J. T. H., Claessen, N., van der Loos, C. M., der Pant, K. A. M. I. V. D., Bouts, A. H. M., Idu, M. M., Rowshani, A. T., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a24a4b · Cited by 28
“In contrast, FOXP3 was shown to be a reliable marker for Tregs (18, 19) despite the fact that on activation most T cells express FOXP3 transiently (20).”
BackgroundWang, J., & Yang, J. (2016) · Biomedical Reports · doi:10.3892/br.2016.694 · Cited by 28
“Therefore, it is possible to define Tregs more strictly as CD4 + CD25 + Foxp3 + cells (6).”
Epigenetic dynamics during CD4+ T cells lineage commitment
Rodríguez, R. M. A., López‐Larrea, C., & Suárez-Álvarez, B. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.04.020 · Cited by 33
Michaëlsson, J., Barbosa, H. M. R., Jordan, K. A., Chapman, J. M., Brunialti, M. K. C., Neto, W. K., Nukui, Y., Sabino, É. C., Chieia, M. A. T., Oliveira, A. S. B., et al. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-41 · Cited by 34
“a fortuitous event, as recent reports suggest that FOXP3 is also expressed on non regulatory T cells in humans [46,47].”
BackgroundRegulatory T cells in paracoccidioidomycosis
Calich, V. L. G., Mamoni, R. L., & Loures, F. V. (2018) · Virulence · doi:10.1080/21505594.2018.1483674 · Cited by 31
“low levels of Foxp3 without a suppressive function [13].”
BackgroundSignaling Through gp130 Compromises Suppressive Function in Human FOXP3+ Regulatory T Cells
Dhuban, K. B., Bartolucci, S., d'Hennezel, E. B., & Piccirillo, C. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01532 · Cited by 27
“Furthermore, FOXP3 is transiently upregulated in Teff cells upon TCR-activation without endowing them with suppressive function (3, 4), thus blurring the distinction between human Treg and activated Teff cells.”
InfluentialDiverse functions and mechanisms of regulatory T cell in ischemic stroke
Wu, Y., Li, J., Shou, J., Zhang, W., & Chen, C. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113782 · Cited by 26
FOXP3 and GARP (LRRC32): the master and its minion
Probst‐Kepper, M., & Buer, J. (2010) · Biology Direct · doi:10.1186/1745-6150-5-8 · Cited by 27
“First, T-cell receptor (TCR) stimulation of CD4CD25FOXP3 T cells leads to the induction of FOXP3 without interfering with the expression of effector cytokines such as interleukin-2 and interferon-g [15-17].”
BackgroundImmunoregulatory T cells: Role and potential as a target in malignancy
Beyer, M., & Schultze, J. L. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0021-z · Cited by 26
“In humans, however, FOXP3 expression is not confined to T reg cells; recent reports have demonstrated induction of FOXP3 in activated conventional T cells without suppressive activity [8, 9 ].”
BackgroundGovindaraj, C., Scalzo‐Inguanti, K., Scholzen, A., Li, S., & Plebanski, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00233 · Cited by 28
“Moreover, although it has been accepted as dogma that FOXP3 expression turns off IFN-g production (7, 8, 20), our results suggest that upon T cell activation, CD25hiTNFR2+ express not only IFN-g but also IL-2, IL-10, T-bet and thus these T cells FIGURE 3 | Suppressive capacity of inducedTNFR2 T cells.”
BackgroundResultInfluentialLi, Z., Vermeire, S., Bullens, D. M. A., Ferrante, M., Steen, K. V., Noman, M., Rutgeerts, P. J., Ceuppens, J. L., & Assche, G. V. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000509 · Cited by 32
Lundberg, A. K., Jonasson, L., Hansson, G. K., & Mailer, R. K. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.026 · Cited by 27
Negative Feedback Regulation of T Cells via Interleukin-2 and FOXP3 Reciprocity
Popmihajlov, Z., & Smith, K. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001581 · Cited by 27
“By comparison, purified CD4+CD45+CD25-CD127+ human T cells activated with solid-phase anti-CD3+soluble anti-CD28 in the presence of both IL2 and TGFb supplied exogenously results in FOXP3 expression by most remaining cells [35,36].”
BackgroundDC expressing transgene Foxp3 are regulatory APC
Lipscomb, M. W., Taylor, J. L., Goldbach, C., Watkins, S. C., Wesa, A. K., & Storkus, W. J. (2009) · European Journal of Immunology · doi:10.1002/eji.200939667 · Cited by 27
Fernandes, C., Gonçalves, H. D. S., Cabral, P. B. E., Pinto, H., Pinto, M. I. D. M., & Câmara, L. M. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079072 · Cited by 26
“population analyzed included activated cells without regulatory function, which can express CD25 and FOXP3 at lower levels than Treg [14,33].”
BackgroundSOCS1 and Regulation of Regulatory T Cells Plasticity
Takahashi, R., & Yoshimura, A. (2014) · Journal of Immunology Research · doi:10.1155/2014/943149 · Cited by 28
CD4+CD25-FoxP3+T cells: a distinct subset or a heterogeneous population?
Zohouri, M., Mehdipour, F., Razmkhah, M., Faghih, Z. S., & Ghaderi, A. A. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1797005 · Cited by 27
Hu, L., Zhu, M., Shen, Y., Zhong, Z., & Wu, B. Y. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02420-1 · Cited by 26
Frei, A. L., McGuigan, A., Sinha, R. R., Jabbar, F., Gneo, L., Tomasevic, T., Harkin, A., Iveson, T. J., Saunders, M. P., Oien, K. A., et al. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00560-0 · Cited by 34
Fujii, H., Arakawa, A., Kitoh, A., Miyara, M., Kato, M. K., KORE-EDA, S., Sakaguchi, S., Miyachi, Y., Tanioka, M., & Ono, M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10199.x · Cited by 28
Wang, J., van Dongen, H., Scherer, H. U., Huizinga, T. W. J., & Toes, R. E. M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23460 · Cited by 28
“Likewise, not all of the CD4 ,CD127 / cells in human PBMCs are FoxP3 , since CD127 is down-regulated in recently activated effector T cells (22,37).”
BackgroundRegulatory cells and cell signatures in clinical transplantation tolerance
Newell, K. A., Phippard, D., & Turka, L. A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.008 · Cited by 26
“Furthermore in humans, unlike mice, Foxp3 may be transiently expressed by recently activated T effector (Teff) cells [22].”
BackgroundGuillot‐Delost, M., Cheraï, M., Hamel, Y., Rosenzwajg, M., Baillou, C., Simonin, G., Leclercq, V., Mariotti‐Ferrandiz, E., Six, A., Bon‐Durand, V., et al. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1220 · Cited by 26
Ward‐Hartstonge, K. A., McCall, J. L., McCulloch, T. R., Kamps, A.-K., Girardin, A., Cretney, E., Munro, F. M., & Kemp, R. A. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1951-1 · Cited by 28
“FOXP3 can be upregulated transiently on activated T cells and these activated FOXP3+ cells are unable to suppress proliferation or cytokine production [24].”
BackgroundWang, J., Cao, X., Zhao, A., Cai, H., Wang, X., & Li, J. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0687-8 · Cited by 26
Stability of Regulatory T-cell Lineage
Hori, S. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387827-4.00001-2 · Cited by 35
McKay, F. C., Swain, L. I., Schibeci, S. D., Rubio, J. P., Kilpatrick, T. J., Heard, R. N., Stewart, G. J., & Booth, D. R. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.02.003 · Cited by 29
Transcriptional Control of Regulatory T-Cell Differentiation
van der Veeken, J., Arvey, A. J., & Rudensky, A. Y. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020289 · Cited by 25
“Similarly, human CD4 T cells transiently express low levels of Foxp3 following TCR stimulation, while maintaining CNS2 in a methylated state (Gavin et al. 2006; Allan et al. 2007; Tran et al. 2007; Wang et al. 2007; Nagar et al. 2008).”
BackgroundYe, L., GOODALL, J. C., Zhang, L., Putintseva, E. V., Lam, B., Jiang, L., Liu, W., Yin, J., Lin, L., Li, T., et al. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.90 · Cited by 29
Molecular Markers Distinguishing T Cell Subtypes With TSDR Strand-Bias Methylation
Minskaia, E., Saraiva, B. C., Soares, M. V. D., Azevedo, R. I., Ribeiro, R. M., Kumar, S., Vieira, A. I. S., & de Lacerda, J. F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02540 · Cited by 28
“As α(1, 3)-fucosyltransferase 7 (FUT7) mediates synthesis of CD15s expressed in both eTregs and CD34 cells (12), FUT7 promoter was expected to be demethylated in these cell populations to allow for protein expression.”
BackgroundInfluentialMorina, L., Jones, M., Oguz, C., Kaplan, M. J., Gangaplara, A., Fitzhugh, C. D., Kanakry, C. G., Shevach, E. M., & Buszko, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1114780 · Cited by 27
Beyer, M., Schumak, B., Weihrauch, M. R., Andres, B., Giese, T., Endl, E., Knolle, P. A., Claßen, S., Limmer, A., & Schultze, J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030422 · Cited by 27
“exclusively on Treg cells in the mouse [2], while data concerning its expression in humans are not as clear-cut [8,9].”
BackgroundNo association between vitamin D and β‐cell autoimmunity in Finnish and Estonian children
Reinert‐Hartwall, L., Honkanen, J. K., Härkönen, T., Ilonen, J., Simell, O., Peet, A., Tillmann, V., Lamberg-Allardt, C. J. E., Virtanen, S. M., Knip, M., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2550 · Cited by 36
“In humans, T-cell activation results in the up-regulation of FOXP3 as well in effector T cells, in which this response is important for the inhibition of T-cell activation [40,41].”
BackgroundDevelopment of CD4+CD25+FoxP3+ regulatory T cells from cord blood hematopoietic progenitor cells
Hutton, J. F., Gargett, T., Sadlon, T. J., Bresatz, S., Brown, C. Y., Zola, H., Shannon, M. F., D’Andrea, R. J., & Barry, S. C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008620 · Cited by 25
“4 Journal of Leukocyte Biology Volume 85, March 2009 http://www.jleukbio.org are akin to nTregs and do not represent an activation-induced, transient FoxP3 population [ 24 ].”
BackgroundFOXP3+regulatory T cells as biomarkers in human malignancies
Bignone, P. A., & Banham, A. H. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712590802494022 · Cited by 26
“The literature concerning whether FOXP3 constitutes a bona fide marker for human regulatory T cells is comprehensively discussed in [26-31] and also in a recent review by Roncarolo and Gregori [5] and thus there is no need to duplicate their efforts here.”
BackgroundRegulatory T cells—the renaissance of the suppressor T cells
Bopp, T., Jonuleit, H., & Schmitt, E. (2007) · Annals of Medicine · doi:10.1080/07853890701379700 · Cited by 33
Brown, C. Y., Sadlon, T. J., Hope, C. M., Wong, Y. Y., Wong, S. W., Liu, N., Withers, H., Brown, K., Bandara, V., Gundsambuu, B., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01269 · Cited by 26
Figliuolo, V. R., Jamwal, D. R., & Kiela, P. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_9 · Cited by 29
Stachtea, X., Loughrey, M. B., Salvucci, M., Lindner, A. U., Cho, S., McDonough, E., Sood, A., Graf, J. F., Santamaría-Pang, A., Corwin, A. D., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00953-0 · Cited by 25
Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies
Viveiros, N., Flores, B. C. T., Lobo, J., Martins‐Lima, C., Cantante, M., Lopes, P., Deantonio, C., Palu, C. C., Sainson, R. C. A., Henrique, R., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1402 · Cited by 24
“Previous studies have reported a temporary expression of this transcriptional regulator during the activation process of CD4 and CD8 effector T cells, which is insufficient to induce an immunosuppressive phenotype, characterised by the ability to limit proinflammatory factors, such as interferon-γ.(56,57) This is cons…”
BackgroundYang, E. Y., Kronenfeld, J. P., Gattás‐Asfura, K. M., Bayer, A. L., & Stabler, C. L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.009 · Cited by 26
Subpopulations of helper T lymphocytes in tuberculous pleurisy
Tong, Z.-H., & Shi, H. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.02.014 · Cited by 25
Mittag, D., Scholzen, A., Varese, N. P., Baxter, L., Paukovics, G., Harrison, L. C., Rolland, J. M., & O’Hehir, R. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901036 · Cited by 24
Glišić, S., Ehlenbach, S. J., Jailwala, P., Waukau, J., Jana, S., & Ghosh, S. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0900-0 · Cited by 24
“…that Foxp3 after activation is transient in nature in humans (Wang et al. 2007b), we have based our conclusions more on functional differences, since cells with activation-induced Foxp3 expression in human T effector cells have been reported not to suppress proliferation (Allan et al. 2007).”
Background[Mechanisms of suppression of regulatory T-cells (Treg)].
Flores, J. M. G., & Portales‐Pérez, D. P. (2013) · PubMed · Cited by 27
Mastracci, L., Fontana, V., Queirolo, P., Carosio, R., Grillo, F., Morabito, A., Banelli, B., Tanda, E. T., Boutros, A., Dozin, B., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02494-y · Cited by 28
Sahin, M. A., Şahın, E., & Köksoy, S. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.05.009 · Cited by 23
Koster, B. D., Santegoets, S. J. A. M., Harting, J., Baars, A., van Ham, S. M., Scheper, R. J., Hooijberg, E., de Gruijl, T. D., & van den Eertwegh, A. J. M. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02320-0 · Cited by 23
The Dendritic Cell Dilemma in the Skin: Between Tolerance and Immunity
Scheib, N., Tiemann, J., Becker, C., Probst, H. C., Raker, V., & Steinbrink, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.929000 · Cited by 27
“Despite methodological difficulty in reliably identifying human Treg (74, 75), a number of papers have demonstrated that most autoimmune diseases are accompanied by defects in the number or function of peripheral blood Treg, and these observations could be confirmed by in vivo disease models (76).”
BackgroundRegulatory T-Cell Differentiation and Their Function in Immune Regulation
Piccioni, M., Chen, Z., Tsun, A., & Li, B. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_4 · Cited by 28
Identification of a human Th1-like IFNγ-secreting Treg subtype deriving from effector T cells
Venigalla, R. K., Guttikonda, P. J., Eckstein, V., Ho, A. D., Sertel, S., Lorenz, H., & Tretter, T. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.06.004 · Cited by 31
von Toerne, C., Sieg, C., Kaufmann, U., Diedrichs‐Möhring, M., Nelson, P. J., & Wildner, G. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.07.017 · Cited by 26
Jaberi‐Douraki, M., Pietropaolo, M., & Khadra, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093326 · Cited by 26
“Such transient behavior has been already demonstrated for certain T-cell biomarkers such as FoxP3 and CD25 in effector Tcells for self-regulation [43].”
Hughson, A. L., Bromberg, I., Johnson, B. D., Quataert, S. A., Jospe, N., & Fowell, D. J. (2011) · Diabetes · doi:10.2337/db10-1661 · Cited by 23
T-cell-based immunotherapy of autoimmune diseases
Ulivieri, C., & Baldari, C. T. (2013) · Expert Review of Vaccines · doi:10.1586/erv.12.146 · Cited by 25
Hilchey, S. P., & Bernstein, S. H. (2007) · Immunological Investigations · doi:10.1080/08820130701674463 · Cited by 25
“However, despite the apparent specificity for Tregs in mice, expression of FOXP3 in humans appears more complicated, as activated effector T-cells have also been shown to transiently express FOXP3 but lack suppressive activity, making human ex vivo identification of Tregs using FOXP3 imprecise (Allan et al., 2007).”
BackgroundMiguel, A., Sendra, L., Noé, V., Ciudad, C. J., Dasí, F., Hervás, D., Herrero, M. J., & Aliño, S. F. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s104393 · Cited by 24
Schilbach, K., Krickeberg, N., Kaißer, C., Mingram, S., Kind, J., Siegers, G. M., & Hashimoto, H. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02469-8 · Cited by 24
“This suggests that Foxp3 is a transient activation marker rather than a regulatory marker analogous to Foxp3 expression in activated human CD4 αβ T helper cells [66, 67].”
BackgroundImmune Dysregulation in Primary Immunodeficiency Disorders
Torgerson, T. R. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.02.002 · Cited by 22
Role of Regulatory and Proinflammatory T-Cell Populations in Allergic Diseases
Orihara, K., Nakae, S., Pawankar, R., & Saito, H. (2008) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3181629ae3 · Cited by 23
Seidel, M. G., & Hauck, F. H. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.12.022 · Cited by 24
Metadata
- Authors
- Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-20
- Volume
- 19
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2139019810
- Cited by
- 872
- References
- 39
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 24 · 2023: 21 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 26 · 2015: 46 · 2014: 62 · 2013: 62 · 2012: 67
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, CD4+CD25+ T cells, T cell activation, T cell proliferation, cytokine production, CD127, interleukin-2, interferon-gamma, immune tolerance, human T cells
- MeSH terms
- CD69 Antigens, Antibodies, Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, Cell Line, Cysteine, Flagellin, Humans, Interferon-gamma, Interleukin-2, Lipoproteins, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, CD3 Complex, Receptors, Nerve Growth Factor, Clonal Anergy, CD28 Antigens, Receptors, Tumor Necrosis Factor, Coculture Techniques, Lectins, C-Type, Cell Proliferation, T-Lymphocytes, Regulatory, Toll-Like Receptors, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.